Croatia osiguranje (CROS) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
2 Jul, 2026Executive summary
Total income from insurance contracts rose 13.4% year-over-year to EUR 285.1m, with non-life insurance income up 13.6% and life insurance income up 8.4%.
Net profit increased 25% year-over-year to EUR 42m, and net result from insurance contracts grew 32.9% to EUR 24.1m.
Total assets reached EUR 1.9bn, up 8% from year-end 2024; insurance contract liabilities rose 4% to EUR 893.9m.
Financial highlights
Earnings per share increased from EUR 79.7 to EUR 99.6 year-over-year.
Cash flow from operating activities was EUR 10.8m, down from EUR 85m in the prior year period.
Dividend of EUR 45.8m (EUR 106.52 per share) was approved and paid in June 2025.
Outlook and guidance
Inflation in Croatia is forecast at 3.6% for 2025, with unemployment expected to fall below 5% and wage growth around 10%.
Non-life insurance premium growth remains solid at 10%, but a slowdown is noted, especially in motor and health insurance.
Life insurance premiums are below last year’s level; no short-term trend changes expected.
Capital adequacy is expected to remain above 200% throughout 2025.
Latest events from Croatia osiguranje
- Net profit surged 43% to EUR 46.3m, driven by strong insurance and digital segment growth.CROS
Q3 20242 Jul 2026 - Insurance income and profit up year-over-year, with strong digital and healthcare growth.CROS
Q2 20242 Jul 2026 - Net profit jumped 39.9% year-over-year, with strong digital and healthcare growth.CROS
Q4 20242 Jul 2026 - Net profit rose 7.5% to EUR 17m, driven by strong insurance and digital segment growth.CROS
Q1 20252 Jul 2026 - Net profit rose 25% to EUR 57.9m, driven by strong insurance and digital segment growth.CROS
Q3 20252 Jul 2026 - Net profit rose 7.2% to EUR 65.5m, driven by non-life and digital business growth.CROS
Q4 20252 Jul 2026 - Insurance income up 10.3% and net profit up 6.8%, with strong digital and capital positions.CROS
Q1 20262 Jul 2026